Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Tau PET Outcomes in Patients Receiving Anti-amyloid Immunotherapies

NCT06723015 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06723015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06723015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Tau PET Outcomes in Patients Receiving Anti-amyloid Immunotherapies
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
November 4, 2025
Completion date
August 31, 2028
Enrollment
135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, mild, dementia, mild